A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month forecast lower-than ...

picture alliance / Getty Images Weight-loss drugs are transforming both health care and Wall Street, with leading manufacturers like Eli Lilly & Co. (LLY) and Novo Nordisk A/S (NVO) seeing stock ...

Drug compounders making copycat versions of Eli Lilly & Co. ’s tirzepatide are urging a federal judge to shield them from FDA enforcement while a court decides whether the agency lawfully stopped ...

Learn how to get Zepbound online, in-person, and through the drug’s manufacturer, Eli Lilly ... a doctor will assess your current health, weight-loss goals, and eligibility for the drug.

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

Hims & Hers revealed that it will make its Big Game debut with a minute-long ad highlighting its compounded GLP-1 weight loss drug offerings ... GLP-1 phenomenon. Eli Lilly and Novo Nordisk have had ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past several ...

In a few short years, excitement about groundbreaking anti-obesity drugs made Novo ... to-head trial run by Eli Lilly confirmed that Zepbound offered greater weight loss than Wegovy.

NEW YORK, Jan 22 — A new study highlighted Monday the potential benefits of popular diabetes drugs on a ... (Ozempic/Wegovy) and Eli Lilly (Mounjaro). Multiple studies had already shown that their ...